AEterna Zentaris Inc.

(AEZS) Trade

By |

Profile

AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company is actively pursuing opportunities to commercialize macimorelin in the EU & the rest of the world.

Contact Information

Website: www.zentaris.com
Email: ir@aezsinc.com
Main Phone: +1 843 900-3223
Address: 315 Sigma Drive
Address 2: Suite 302D
State: SC
City / Town: Summerville
Country: US
Postal Code: 29486

Issuer Information

Exchange: NSC
CEO: Klaus Paulini
Employees: 11
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More

Profile

AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company is actively pursuing opportunities to commercialize macimorelin in the EU & the rest of the world.

Contact Information

Website: www.zentaris.com
Email: ir@aezsinc.com
Main Phone: +1 843 900-3223
Address: 315 Sigma Drive
Address 2: Suite 302D
State: SC
City / Town: Summerville
Country: US
Postal Code: 29486

Issuer Information

Exchange: NSC
CEO: Klaus Paulini
Employees: 11
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

View More
$ 0.35 $ -0.0073 (-2.03%)
Last Price 0.35 Change $ -0.0073 Change % -2.03 Tick N/A
Bid 0.35 Bid Size 700.00 Ask 0.36 Ask Size 100.00
Open 0.36 High 0.36 Low 0.35 Prev Close 0.36
Last Trade Volume 469,361 52 Wk Hi 1.54 52 Wk Low 0.33
Market Cap 22.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 53,482,263.00 EPS (TTM) -0.81 PE Ratio N/A Exchange NCM
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 4 4 4 4
Low Target Price Estimate 3 3 3 3
Mean Target Price Estimate 3.5 3.5 3.5 3.5
Standard Deviation 0.71 0.71 0.71 0.71
Date of Most Recent Estimate 04/05/18 04/05/18 04/05/18 04/05/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1